Company Profile
Teva Pharmaceutical Industries Stock Price, News & Analysis
- Ticker:
- TEVA
- Exchange:
- NYSE
- Sector:
- 药物开发
- Location:
- Headquartered in the United States and listed on NYSE, Teva Pharmaceutical Industries is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
33.21 USD (+3.14%)
Close
Last updated: June 23, 2026 at 00:00
38.67B USD
Market cap
Why the stock is moving
TEVA is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Teva Pharmaceutical Industries is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, Teva Pharmaceutical Industries is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Teva Pharmaceutical Industries follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Teva Pharmaceutical Industries sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Teva Pharmaceutical Industries (TEVA)?
Teva Pharmaceutical Industries (TEVA) most recently closed at 33.21 USD, a +3.14% move versus the previous session.
What is the market cap of Teva Pharmaceutical Industries (TEVA)?
Teva Pharmaceutical Industries currently has a market capitalization of 38.67B USD on BioPharmSignal.
What does Teva Pharmaceutical Industries do?
Teva Pharmaceutical Industries is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is TEVA stock listed?
Teva Pharmaceutical Industries (TEVA) is associated with NYSE, Headquartered in the United States and listed on NYSE, Teva Pharmaceutical Industries is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., 药物开发.
What is Teva?
Teva Pharmaceutical Industries is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Teva Pharmaceutical Industries targeting with Teva?
Teva Pharmaceutical Industries is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Pharmaceutical?
Teva Pharmaceutical Industries is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Industries?
Teva Pharmaceutical Industries is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.